Active-specific immunotherapy of pancreatic carcinoma: Usefulness of human pancreatic carcinomas in preparing autologous tumor vaccines

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 3117-3119

  Großmann, Armin ^a   Rameken, Monika ^b   Klapdor, Rainer ^b  

^a Macrolab GmbH   (Germany)

^b Zentrum F Tumormarker Diagn T   (Germany)

Author keywords

Immunotherapy; Interferon gamma; MHC; Mouse model; Pancreatic carcinoma; Tumor vaccine

Indexed keywords

ALPHA TOCOPHEROL; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR VACCINE;

ANIMAL CELL; ANTIGEN EXPRESSION; CANCER IMMUNOTHERAPY; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; CANCER VACCINES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOTHERAPY, ACTIVE; MICE; MICE, INBRED BALB C; MICE, NUDE; PANCREATIC NEOPLASMS;

EID: 1842408944     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Restifo NP, Kawakami Y, Marincola F, Shamamian P, Taggarse A, Esquivel F, Rosenberg SA: Molecular mechanism used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class 1. J Immunother 14: 182-190, 1993.
2. Cohen EP, Kim TS: Neoplastic cells that express low levels of MHC class I determinants escape host immunity. Semin Cancer Biol 5: 19-28, 1994.
3. Jessup JM, Posner M, Hubermann M: Influence of multimodality therapy on the management of pancres carcinoma. Semin Surg Oncol 9: 27-32, 1993.
4. Lygidakis NJ, Savanis G, Toloupakis E, Katsikoyiannis N, Kapenanakis A, Pothoulakis J, Maganas D, Papadimitriou A, Batziotis N, Zisimopoulos A: Induced in vivo targeted transarterial and transvenous immunostimulation in patients with unresectable pancreatic carcinoma. Hepatogastroenterology 40: 574-581, 1993.
5. Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A: Tumor antigens recognized by T lymphocytes. Ann Rev Immunol 12: 337-365, 1994.
6. Oka M, Suzuki T: Strategy of treatment for pancreatic and biliary cancer with special reference to immunotherapy. Gan To Kagaku Ryoho 21: 1571-1576, 1994.